These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24852140)

  • 1. Mouse lung infection model to assess Rhodococcus equi virulence and vaccine protection.
    González-Iglesias P; Scortti M; MacArthur I; Hapeshi A; Rodriguez H; Prescott JF; Vazquez-Boland JA
    Vet Microbiol; 2014 Aug; 172(1-2):256-64. PubMed ID: 24852140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment in mice of vapA-DNA vaccination against Rhodococcus equi infection.
    Haghighi HR; Prescott JF
    Vet Immunol Immunopathol; 2005 Apr; 104(3-4):215-25. PubMed ID: 15734542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to vaccines based upon the VapA protein of the horse pathogen, Rhodococcus equi, in a murine model.
    Vanniasinkam T; Barton MD; Heuzenroeder MW
    Int J Med Microbiol; 2005 Jan; 294(7):437-45. PubMed ID: 15715172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal vaccination with attenuated Salmonella expressing VapA: TLR2 activation is not essential for protection against R. equi infection.
    Cardoso SA; Oliveira AF; Ruas LP; Trevisani MM; De Oliveira LL; Hanna ES; Roque-Barreira MC; Soares SG
    Vaccine; 2013 Sep; 31(41):4528-35. PubMed ID: 23933366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric vapA/groEL2 DNA vaccines enhance clearance of Rhodococcus equi in aerosol challenged C3H/He mice.
    Phumoonna T; Barton MD; Vanniasinkam T; Heuzenroeder MW
    Vaccine; 2008 May; 26(20):2457-65. PubMed ID: 18423949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine.
    Cauchard J; Sevin C; Ballet JJ; Taouji S
    Vet Microbiol; 2004 Nov; 104(1-2):73-81. PubMed ID: 15530741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral administration of a live attenuated Salmonella vaccine strain expressing the VapA protein induces protection against infection by Rhodococcus equi.
    Oliveira AF; Ferraz LC; Brocchi M; Roque-Barreira MC
    Microbes Infect; 2007 Mar; 9(3):382-90. PubMed ID: 17307012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal co-immunization of mice with recombinant lactococci secreting VapA antigen and leptin elicits a protective immune response against Rhodococcus equi infection.
    Cauchard S; Bermúdez-Humarán LG; Blugeon S; Laugier C; Langella P; Cauchard J
    Vaccine; 2011 Dec; 30(1):95-102. PubMed ID: 22019740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a live, attenuated, potential vaccine strain of R. equi expressing vapA and the virR operon, and virulence assessment in the mouse.
    Whitehead AE; Parreira VR; Hewson J; Watson JL; Prescott JF
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):479-84. PubMed ID: 22088674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi.
    Lopez AM; Hines MT; Palmer GH; Knowles DP; Alperin DC; Hines SA
    Vaccine; 2003 Sep; 21(25-26):3815-25. PubMed ID: 12922115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the immunogenic potential of Rhodococcus equi virulence associated protein (VapA) in mice.
    Prescott JF; Patterson MC; Nicholson VM; Morein B; Yager JA
    Vet Microbiol; 1997 Jun; 56(3-4):213-25. PubMed ID: 9226836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Rhodococcus equi virulence-associated protein for immunization of foals against R equi pneumonia.
    Prescott JF; Nicholson VM; Patterson MC; Zandona Meleiro MC; Caterino de Araujo A; Yager JA; Holmes MA
    Am J Vet Res; 1997 Apr; 58(4):356-9. PubMed ID: 9099378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of vaccine candidates against Rhodococcus equi in BALB/c mice infection model: cellular and humoral immune responses.
    Liu L; Cai P; Gu W; Duan X; Gao S; Ma X; Ma Y; Ma S; Li G; Wang X; Cai K; Wang Y; Cai T; Zhao H
    BMC Microbiol; 2024 Jul; 24(1):249. PubMed ID: 38977999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a live-attenuated auxotrophic candidate vaccine against the intracellular pathogen Rhodococcus equi.
    Lopez AM; Townsend HG; Allen AL; Hondalus MK
    Vaccine; 2008 Feb; 26(7):998-1009. PubMed ID: 18055071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenecity of synthetic peptides representing linear B-cell epitopes of VapA of Rhodococcus equi.
    Taouji S; Nomura I; Giguère S; Tomomitsu S; Kakuda T; Ganne V; Takaï S
    Vaccine; 2004 Mar; 22(9-10):1114-23. PubMed ID: 15003638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi.
    Giguère S; Hondalus MK; Yager JA; Darrah P; Mosser DM; Prescott JF
    Infect Immun; 1999 Jul; 67(7):3548-57. PubMed ID: 10377138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VapA-specific IgG and IgG subclasses responses after natural infection and experimental challenge of foals with Rhodococcus equi.
    Sanz MG; Villarino N; Ferreira-Oliveira A; Horohov DW
    Vet Immunol Immunopathol; 2015 Mar; 164(1-2):10-5. PubMed ID: 25681111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of vapA encoding Virulence Associated Protein A attenuates the intracellular actinomycete Rhodococcus equi.
    Jain S; Bloom BR; Hondalus MK
    Mol Microbiol; 2003 Oct; 50(1):115-28. PubMed ID: 14507368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of a lipid-modified virulence-associated protein of Rhodococcus equi and its potential in protective immunity.
    Tan C; Prescott JF; Patterson MC; Nicholson VM
    Can J Vet Res; 1995 Jan; 59(1):51-9. PubMed ID: 7704843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunogenicity of Rhodococcus equi GroEL2-based vaccines in a murine model.
    Vanniasinkam T; Barton MD; Heuzenroeder MW
    Vet Immunol Immunopathol; 2004 Mar; 98(1-2):91-100. PubMed ID: 15127846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.